These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31682856)

  • 1. The 5-HT
    Chaumont-Dubel S; Dupuy V; Bockaert J; Bécamel C; Marin P
    Neuropharmacology; 2020 Aug; 172():107839. PubMed ID: 31682856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
    Millan MJ; Dekeyne A; Gobert A; Brocco M; Mannoury la Cour C; Ortuno JC; Watson D; Fone KCF
    Neuropharmacology; 2020 Oct; 177():108099. PubMed ID: 32525060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 5-HT
    Chaumont-Dubel S; Galant S; Prieur M; Bouschet T; Bockaert J; Marin P
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
    Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central 5-HT receptors and their function; present and future.
    Sharp T; Barnes NM
    Neuropharmacology; 2020 Oct; 177():108155. PubMed ID: 32522572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development.
    Grimaldi B; Bonnin A; Fillion MP; Ruat M; Traiffort E; Fillion G
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):393-400. PubMed ID: 9606024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Serotonin 5-HT
    Doucet E; Grychowska K; Zajdel P; Bockaert J; Marin P; Bécamel C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.
    Martin PY; Doly S; Hamieh AM; Chapuy E; Canale V; Drop M; Chaumont-Dubel S; Bantreil X; Lamaty F; Bojarski AJ; Zajdel P; Eschalier A; Marin P; Courteix C
    Prog Neurobiol; 2020 Oct; 193():101846. PubMed ID: 32512114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.
    Nirogi R; Jayarajan P; Shinde A; Mohammed AR; Grandhi VR; Benade V; Goyal VK; Abraham R; Jasti V; Cummings J
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT
    Brodsky M; Lesiak AJ; Croicu A; Cohenca N; Sullivan JM; Neumaier JF
    Brain Res; 2017 Apr; 1660():10-19. PubMed ID: 28087224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
    Kohen R; Metcalf MA; Khan N; Druck T; Huebner K; Lachowicz JE; Meltzer HY; Sibley DR; Roth BL; Hamblin MW
    J Neurochem; 1996 Jan; 66(1):47-56. PubMed ID: 8522988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES; Neumaier JF
    Pharmacol Ther; 2005 Dec; 108(3):320-33. PubMed ID: 16005519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
    Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
    Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual 5-HT
    Grychowska K; Chaumont-Dubel S; Kurczab R; Koczurkiewicz P; Deville C; Krawczyk M; Pietruś W; Satała G; Buda S; Piska K; Drop M; Bantreil X; Lamaty F; Pękala E; Bojarski AJ; Popik P; Marin P; Zajdel P
    ACS Chem Neurosci; 2019 Jul; 10(7):3183-3196. PubMed ID: 30896921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitory compound against the interaction between G alpha(s) and the third intracellular loop region of serotonin receptor subtype 6 (5-HT6) disrupts the signaling pathway of 5-HT6.
    Choi YH; Kang H; Lee WK; Kim T; Rhim H; Yu YG
    Exp Mol Med; 2007 Jun; 39(3):335-42. PubMed ID: 17603287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptors of type 6 (5-HT6): what can we expect from them?
    Marazziti D; Baroni S; Catena Dell'Osso M; Bordi F; Borsini F
    Curr Med Chem; 2011; 18(18):2783-90. PubMed ID: 21649582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and atypical pathways for serotonin signaling.
    Bockaert J; Bécamel C; Chaumont-Dubel S; Claeysen S; Vandermoere F; Marin P
    Fac Rev; 2021; 10():52. PubMed ID: 34195691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons.
    Wada K; Hu L; Mores N; Navarro CE; Fuda H; Krsmanovic LZ; Catt KJ
    Mol Endocrinol; 2006 Jan; 20(1):125-35. PubMed ID: 16109737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.